Search Results - "Oostra, Drew R"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Romidepsin-associated cardiac toxicity and ECG changes: A case report and review of the literature by Rivers, Zachary T, Oostra, Drew R, Westholder, James S, Vercellotti, Gregory M

    Published in Journal of oncology pharmacy practice (01-01-2018)
    “…Background Romidepsin is a novel histone deacetylase inhibitor that is approved for the treatment of cutaneous and peripheral T-cell lymphoma in patients who…”
    Get full text
    Journal Article
  2. 2

    Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer by Oostra, Drew R., Lustberg, Maryam B., Reinbolt, Raquel E., Pan, Xueliang, Wesolowski, Robert, Shapiro, Charles L.

    Published in Molecular and cellular endocrinology (15-02-2015)
    “…•Chemotherapy induced ovarian failure (CIOF) results in rapid bone loss.•Osteoprotegerin (OPG) interrupts osteoclast activation and bone resorption.•We studied…”
    Get full text
    Journal Article
  3. 3

    Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer by Oostra, Drew R, Macrae, Erin R

    Published in Breast cancer targets and therapy (01-01-2014)
    “…Trastuzumab is a monoclonal antibody that is used in the treatment of breast cancer. Trastuzumab targets the human epidermal growth factor receptor 2 (HER2)…”
    Get full text
    Journal Article